Affordable Diabetes & Weight Loss Breakthrough: Indian Pharma Giants Launch Low-Cost Generic Semaglutide Injections
In a major development for healthcare in Indian Pharma, leading pharmaceutical companies have introduced affordable generic versions of semaglutide injections—bringing new hope to millions of people managing Type 2 Diabetes and obesity. With the patent expiration of this widely used drug, Indian pharma giants are now making this advanced treatment significantly more accessible. This move…